| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 26, 2004
Revised on September 2, 2004
Accepted on September 7, 2004
1-Adrenergic Stimulation Modulates Cardiac Contractility by Ca2+/Calmodulin Kinase Signaling Pathway
From the Laboratory of Cardiovascular Sciences (W.W., W.Z., S.W., D.Y., R.-P.X., H.C), National Institute on Aging, National Institutes of Health; Department of Medicine (M.T.C.), Johns Hopkins University, School of Medicine, Baltimore, Md; and The Institute of Molecular Medicine (R.-P.X., H.C.), Peking University, Beijing, China.
* To whom correspondence should be addressed. E-mail: chengp{at}grc.nia.nih.gov.
A tenet of
1-adrenergic receptor (
1AR) signaling is that stimulation of the receptor activates the adenylate cyclase-cAMP-protein kinase A (PKA) pathway, resulting in positive inotropic and relaxant effects in the heart. However, recent studies have suggested the involvement of Ca2+/calmodulin-dependent protein kinase II (CaMKII) in
1AR-stimulated cardiac apoptosis. In this study, we determined roles of CaMKII and PKA in sustained versus short-term
1AR modulation of excitation-contraction (E-C) coupling in cardiac myocytes. Short-term (10-minute) and sustained (24-hour)
1AR stimulation with norepinephrine similarly enhanced cell contraction and Ca2+ transients, in contrast to anticipated receptor desensitization. More importantly, the sustained responses were largely PKA-independent, and were sensitive to specific CaMKII inhibitors or adenoviral expression of a dominant-negative CaMKII mutant. Biochemical assays revealed that a progressive and persistent CaMKII activation was associated with a rapid desensitization of the cAMP/PKA signaling. Concomitantly, phosphorylation of phospholamban, an SR Ca2+ cycling regulatory protein, was shifted from its PKA site (16Ser) to CaMKII site (17Thr). Thus,
1AR stimulation activates dual signaling pathways mediated by cAMP/PKA and CaMKII, the former undergoing desensitization and the latter exhibiting sensitization. This finding may bear important etiological and therapeutical ramifications in understanding
1AR signaling in chronic heart failure.
1-adrenergic receptor
Ca2+/calmodulin-dependent protein kinase II
cAMP-dependent protein kinase
cardiac contractility
phospholamban
This article has been cited by other articles:
![]() |
T. Aiba, G. G. Hesketh, T. Liu, R. Carlisle, M. C. Villa-Abrille, B. O'Rourke, F. G. Akar, and G. F. Tomaselli Na+ channel regulation by Ca2+/calmodulin and Ca2+/calmodulin-dependent protein kinase II in guinea-pig ventricular myocytes Cardiovasc Res, October 30, 2009; (2009) cvp324v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cappuzzello, M. Napolitano, D. Arcelli, G. Melillo, R. Melchionna, L. Di Vito, D. Carlini, L. Silvestri, S. Brugaletta, G. Liuzzo, et al. Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients Physiol Genomics, August 7, 2009; 38(3): 233 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, Z. Gao, B. Chen, O. M. Koval, M. V. Singh, X. Guan, T. J. Hund, W. Kutschke, S. Sarma, I. M. Grumbach, et al. From the Cover: Calmodulin kinase II is required for fight or flight sinoatrial node physiology PNAS, April 7, 2009; 106(14): 5972 - 5977. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, S. Tandan, J. Cheng, C. Yang, L. Nguyen, J. Sugianto, J. L. Johnstone, Y. Sun, and J. A. Hill Ca2+/Calmodulin-dependent Protein Kinase II-dependent Remodeling of Ca2+ Current in Pressure Overload Heart Failure J. Biol. Chem., September 12, 2008; 283(37): 25524 - 25532. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mattiazzi, L. Vittone, and C. Mundina-Weilenmann Ca2+-Calmodulin-Dependent Protein Kinase Phosphorylation of Ryanodine Receptor May Contribute to the {beta}-Adrenergic Regulation of Myocardial Contractility Independently of Increases in Heart Rate Circ. Res., July 3, 2008; 103(1): e10 - e11. [Full Text] [PDF] |
||||
![]() |
L. F. Couchonnal and M. E. Anderson The Role of Calmodulin Kinase II in Myocardial Physiology and Disease Physiology, June 1, 2008; 23(3): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Metrich, A. Lucas, M. Gastineau, J.-L. Samuel, C. Heymes, E. Morel, and F. Lezoualc'h Epac Mediates {beta}-Adrenergic Receptor-Induced Cardiomyocyte Hypertrophy Circ. Res., April 25, 2008; 102(8): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kohr, H. Wang, D. G. Wheeler, M. Velayutham, J. L. Zweier, and M. T. Ziolo Targeting of phospholamban by peroxynitrite decreases {beta}-adrenergic stimulation in cardiomyocytes Cardiovasc Res, January 15, 2008; 77(2): 353 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
>A. V. Smrcka, E. A. Oestreich, B. C. Blaxall, and R. T. Dirksen EPAC regulation of cardiac EC coupling J. Physiol., November 1, 2007; 584(3): 1029 - 1031. [Full Text] [PDF] |
||||
![]() |
L. P. Collis, S. Srivastava, W. A. Coetzee, and M. Artman beta2-Adrenergic receptor agonists stimulate L-type calcium current independent of PKA in newborn rabbit ventricular myocytes Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2826 - H2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kang, K. Y. Chung, and J. W. Walker G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart Physiology, June 1, 2007; 22(3): 174 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, A. Y.-H. Woo, D. Yang, H. Cheng, M. T. Crow, and R.-P. Xiao Activation of CaMKII{delta}C Is a Common Intermediate of Diverse Death Stimuli-induced Heart Muscle Cell Apoptosis J. Biol. Chem., April 6, 2007; 282(14): 10833 - 10839. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yurukova, A. Kilic, K. Volker, K. Leineweber, N. Dybkova, L. S. Maier, O.-E. Brodde, and M. Kuhn CaMKII-mediated increased lusitropic responses to {beta}-adrenoreceptor stimulation in ANP-receptor deficient mice Cardiovasc Res, March 1, 2007; 73(4): 678 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Sipido CaM or cAMP: Linking {beta}-Adrenergic Stimulation to 'Leaky' RyRs Circ. Res., February 16, 2007; 100(3): 296 - 298. [Full Text] [PDF] |
||||
![]() |
D. Yang, W.-Z. Zhu, B. Xiao, D. X.P. Brochet, S.R. W. Chen, E. G. Lakatta, R.-P. Xiao, and H. Cheng Ca2+/Calmodulin Kinase II-Dependent Phosphorylation of Ryanodine Receptors Suppresses Ca2+ Sparks and Ca2+ Waves in Cardiac Myocytes Circ. Res., February 16, 2007; 100(3): 399 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Curran, M. J. Hinton, E. Rios, D. M. Bers, and T. R. Shannon {beta}-Adrenergic Enhancement of Sarcoplasmic Reticulum Calcium Leak in Cardiac Myocytes Is Mediated by Calcium/Calmodulin-Dependent Protein Kinase Circ. Res., February 16, 2007; 100(3): 391 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hart, E. Dawson, P. Rasmussen, K. George, N. H. Secher, G. Whyte, and R. Shave {beta}-Adrenergic receptor desensitization in man: insight into post-exercise attenuation of cardiac function J. Physiol., December 1, 2006; 577(2): 717 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, W.-Z. Zhu, M.-l. Joiner, R. Zhang, C. V. Oddis, Y. Hou, J. Yang, E. E. Price, L. Gleaves, M. Eren, et al. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3065 - H3075. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Sucharov, P. D. Mariner, K. R. Nunley, C. Long, L. Leinwand, and M. R. Bristow A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1299 - H1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ji, W. Zhao, B. Li, J. Desantiago, E. Picht, M. A. Kaetzel, J. E. J. Schultz, E. G. Kranias, D. M. Bers, and J. R. Dedman Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H599 - H606. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Anderson The Fire From Within: The Biggest Ca2+ Channel Erupts and Dribbles Circ. Res., December 9, 2005; 97(12): 1213 - 1215. [Full Text] [PDF] |
||||
![]() |
M. Reppel, P. Sasse, R. Piekorz, M. Tang, W. Roell, Y. Duan, A. Kletke, J. Hescheler, B. Nurnberg, and B. K. Fleischmann S100A1 Enhances the L-type Ca2+ Current in Embryonic Mouse and Neonatal Rat Ventricular Cardiomyocytes J. Biol. Chem., October 28, 2005; 280(43): 36019 - 36028. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, X. Zeng, M. Zheng, and R.-P. Xiao The Enigma of {beta}2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly Circ. Res., September 16, 2005; 97(6): 507 - 509. [Full Text] [PDF] |
||||
![]() |
N. Lindegger and E. Niggli Paradoxical SR Ca2+ release in guinea-pig cardiac myocytes after {beta}-adrenergic stimulation revealed by two-photon photolysis of caged Ca2+ J. Physiol., June 15, 2005; 565(3): 801 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xiao, M. T. Jiang, M. Zhao, D. Yang, C. Sutherland, F. A. Lai, M. P. Walsh, D. C. Warltier, H. Cheng, and S. R. W. Chen Characterization of a Novel PKA Phosphorylation Site, Serine-2030, Reveals No PKA Hyperphosphorylation of the Cardiac Ryanodine Receptor in Canine Heart Failure Circ. Res., April 29, 2005; 96(8): 847 - 855. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |